Litigation Forecasting Practice

We Forecast High-Profile Cases for Institutional Investors and Corporate Clients

Our clients include:

• Mutual fund managers
• Hedge fund managers
• National brokerage firms
• Financial newsletters
• CEO, in-house counsel

Complex Litigation Specialists

• Patent and other intellectual property
  • Big Pharma v. Generics (Hatch-Waxman Act suits) including Prilosec®, Fosamax®, Levaquin®, Lipitor®, and LexaPro®, numerous others
  • Biotechnology
  • Medical devices
  • Electronics, chips, telecommunications, and tech sector
• Antitrust investigations, enforcement actions, and civil cases
• Securities class actions
• Other complex litigation
• FDA, FTC, ITC administrative proceedings, litigation, appeals

Unbiased Analysis at Key Litigation Milestones

• Pre-complaint portfolio review and due diligence
  • Analysis of a patent case’s strength and scope of patents asserted; Markman issues
• Complaint & case analysis
  • Motions to dismiss and summary judgment
  • Defenses, parties’ positions, and likely outcomes
• Post trial motions and appeals
• Parties’ strategic options, likely moves, timing, results

Your Eyes and Ears at Trial

• Daily reports of trial highlights, testimony, witness effectiveness, and color commentary
• Real-time alerts of surprise developments, shifting prospects
• Periodic big-picture reviews, conference calls

Experienced and Independent Handicapping of Outcomes

• Years of litigation experience, research, and intuition
• Forecasting decision-maker outcomes based on:
  • Case profile
  • Track record of court, judge, and counsel
  • Predisposition of forum and judge
• "It’s not about who’s right or wrong, but who will win, how much and when"

Proven Success Rate

• Early warning in 6-month case worth $.5 billion to client
• Early warning of jury going "off track"
• Prediction of damage amount s and end of jury deliberations
• 90% success in forecasting outcome when covering a full trial